Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

METHOTREXATE-EBEWE™ injection solution 10mg/ml (5ml), vial 1pc

🔥 3 items sold in last 3 hours
10 people are viewing this product
Active Ingredient:

Manufacturer:

$52.0

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

METHOTREXATE-EBEWE™ injection solution 10mg/ml (1.5ml), syringe 1pc

$95.0
Add to cart

METHOTREXATE-EBEWE™ injection solution 10mg/ml (2ml), syringe 1pc

$102.0
Add to cart

Analogs of METHOTREXATE-EBEWE™

METOJECT™ solution for subcutaneous injection 50mg/ml (0.25ml), syringes 1pc

$66.0
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.35ml), syringes 1pc

$96.5
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.4ml), syringes 1pc

$92.5
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.5ml), syringes 1pc

$114.0
Add to cart

Table of Contents

METHOTREXATE-EBEWE™ 10mg Solution 5ml Buy Online

Methotrexate-Ebewe Injection Solution: A Comprehensive Overview

Methotrexate-Ebewe, a potent antineoplastic agent, plays a crucial role in various medical treatments. Its versatility extends beyond cancer therapy, making it a significant medication in the medical arsenal.

This injectable solution, available in a 10mg/ml concentration, offers a convenient and effective method of administration for patients requiring this powerful drug. Understanding its mechanism of action, potential uses, and associated risks is vital for both healthcare professionals and patients.

This overview will delve into the key aspects of Methotrexate-Ebewe injection solution, providing a comprehensive understanding of its applications, administration, and potential side effects. We will explore its role in treating various conditions and discuss essential precautions.

Understanding Methotrexate-Ebewe

Methotrexate-Ebewe injection solution is a cytostatic agent belonging to the class of antimetabolites. Specifically, it’s a folate antagonist, meaning it interferes with the metabolic pathways that utilize folic acid, a crucial vitamin for cell growth and replication. This interference is the cornerstone of its therapeutic action.

By inhibiting dihydrofolate reductase, a key enzyme in folate metabolism, Methotrexate-Ebewe disrupts the synthesis of tetrahydrofolate. This disruption significantly impacts DNA synthesis and cell division, leading to a reduction in the proliferation of rapidly dividing cells, including cancer cells and certain immune cells.

The mechanism of action is multifaceted. Beyond its direct impact on cell growth, Methotrexate-Ebewe also exhibits immunosuppressive effects. This property makes it valuable in managing autoimmune disorders where an overactive immune system attacks the body’s own tissues. This dual action—targeting both rapidly dividing cells and immune system activity—underlies its broad therapeutic applications.

The 10mg/ml concentration of the injectable solution allows for precise dosing, crucial for managing the potential side effects associated with this powerful medication. Careful titration of the dose is often necessary to optimize therapeutic benefits while minimizing adverse reactions. The concentration is consistent across various presentations, ensuring reliable and consistent treatment.

It’s important to note that Methotrexate-Ebewe, like other antimetabolites, carries a risk of significant side effects. Understanding the drug’s mechanism of action is crucial for healthcare professionals to appropriately manage its administration and mitigate potential harm. Patients should always be fully informed about potential risks before commencing treatment.

Therapeutic Applications

Methotrexate-Ebewe’s versatility stems from its ability to target both rapidly dividing cells and the immune system. This dual action makes it a valuable therapeutic agent in a range of conditions. Its primary use is in the treatment of various cancers, where its ability to inhibit cell growth proves crucial.

In oncology, Methotrexate-Ebewe finds application in treating specific types of leukemia and lymphomas, often in combination with other chemotherapeutic agents. Its effectiveness is particularly notable in certain forms of childhood leukemia, where it plays a vital role in established treatment protocols. The precise role and dosage vary depending on the specific cancer type and stage.

Beyond its use in cancer treatment, Methotrexate-Ebewe is also a cornerstone in managing several autoimmune diseases. Its immunosuppressive properties are leveraged to control the overactive immune response characteristic of these conditions. For example, it’s frequently employed in the management of rheumatoid arthritis, a debilitating inflammatory disease affecting the joints.

In the realm of autoimmune diseases, Methotrexate-Ebewe helps to reduce inflammation and slow the progression of joint damage. It can significantly improve symptoms, enabling patients to maintain a better quality of life. However, its use in this context requires careful monitoring due to the potential for significant side effects. Dosage and administration are carefully tailored to individual patient needs.

Other applications may include the treatment of severe psoriasis and psoriatic arthritis, conditions characterized by skin inflammation and joint pain. Its effectiveness in these conditions is linked to its ability to modulate the immune system and reduce inflammation. The specific treatment regimen is determined by the severity of the disease and the patient’s overall health.

Administration and Dosage

Methotrexate-Ebewe injection solution is administered via various routes, depending on the specific condition being treated and the physician’s preference. Common routes include intravenous (IV), intramuscular (IM), and subcutaneous (SC) injections. The choice of route influences the rate of absorption and potential side effects.

Dosage regimens are highly individualized and depend on factors such as the patient’s weight, the specific disease being treated, and the patient’s response to therapy. It is crucial to emphasize that dosage should always be determined and monitored by a qualified healthcare professional. Self-medication is strongly discouraged.

In the treatment of rheumatoid arthritis, for example, a common initial dose might be 7.5mg administered once a week. This dose is often adjusted based on the patient’s response and tolerance. Higher doses may be used in cancer treatment, but these are carefully managed to minimize toxicity. Regular blood tests are frequently employed to monitor for adverse effects.

For some conditions, the medication may be given in a pulsed manner, with higher doses administered less frequently. This approach aims to maximize therapeutic effects while minimizing cumulative toxicity. The frequency and duration of treatment vary significantly, depending on the specific indication and individual patient circumstances.

It’s vital to understand that the administration and dosage of Methotrexate-Ebewe are complex and should be determined solely by a medical professional experienced in managing this medication. Patient adherence to the prescribed regimen is crucial for optimal outcomes and to minimize the risk of adverse events. Any changes in the treatment plan should be discussed with the prescribing physician.

Potential Side Effects

Methotrexate-Ebewe, while highly effective, carries the potential for a range of side effects, varying in severity from mild to life-threatening. The likelihood and severity of these side effects are influenced by factors such as dosage, frequency of administration, and individual patient susceptibility. Close monitoring by a healthcare professional is essential.

Common side effects can include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and mouth sores. These effects are often manageable with appropriate supportive care and may lessen as the body adjusts to the medication. Less frequent but potentially more serious side effects may include liver damage, kidney problems, and bone marrow suppression.

Bone marrow suppression, a serious adverse event, can lead to a decrease in blood cell counts, increasing the risk of infections, bleeding, and anemia. Regular blood tests are crucial to monitor for this complication. Liver function tests are also regularly performed to assess the potential for liver toxicity, a concern particularly in patients with pre-existing liver disease.

Severe allergic reactions, although rare, can occur. These reactions can manifest as skin rashes, itching, difficulty breathing, and swelling of the face, lips, or tongue. Immediate medical attention is required if such symptoms develop. It is vital that patients report any unusual or concerning symptoms to their healthcare provider promptly.

Long-term use of Methotrexate-Ebewe may also carry a risk of lung damage, although this is less common. Patients with pre-existing lung conditions should be carefully monitored. Furthermore, the medication can affect fertility in both men and women, and women of childbearing age should utilize effective contraception during treatment. The potential for teratogenic effects necessitates careful consideration in pregnant or breastfeeding women.

Pros of Methotrexate-Ebewe

Methotrexate-Ebewe offers several key advantages, making it a valuable therapeutic option in specific clinical scenarios. Its effectiveness in various cancers and autoimmune diseases is a significant benefit, providing relief and improved quality of life for many patients. The ability to target both rapidly dividing cells and immune system activity is a unique strength.

The injectable formulation allows for precise dosing and rapid systemic distribution, facilitating quicker therapeutic response compared to oral administration in some cases. This is particularly advantageous in situations requiring urgent intervention or when rapid disease progression necessitates immediate action. The intravenous route, for instance, enables immediate access to the systemic circulation.

For patients with conditions like rheumatoid arthritis, Methotrexate-Ebewe can significantly reduce joint inflammation and pain, improving mobility and daily functioning. This translates to a tangible enhancement of their overall well-being and quality of life. The substantial symptom relief offered can significantly improve the daily lives of affected individuals.

The availability of Methotrexate-Ebewe in a convenient injectable form simplifies administration for both healthcare professionals and patients, particularly in situations where intravenous or intramuscular injections are preferred. This convenience enhances the practicality of treatment, contributing to better patient compliance and treatment adherence.

While potential side effects exist, the benefits of Methotrexate-Ebewe often outweigh the risks for many patients, especially when considering the debilitating nature of the conditions it is used to treat. The careful monitoring and management of potential side effects by healthcare professionals are crucial in realizing the full therapeutic potential of this medication.

Cons of Methotrexate-Ebewe

Despite its therapeutic benefits, Methotrexate-Ebewe carries several potential drawbacks that necessitate careful consideration. The most significant concern revolves around the risk of serious adverse effects, some of which can be life-threatening. Close monitoring and regular blood tests are essential to detect and manage these complications promptly.

Gastrointestinal toxicity is a common side effect, manifesting as nausea, vomiting, and mouth sores. These symptoms can significantly impact a patient’s quality of life and may necessitate dose adjustments or supportive care. In some cases, severe gastrointestinal issues may necessitate temporary discontinuation of treatment.

Methotrexate-Ebewe can suppress bone marrow function, leading to a reduced production of blood cells. This bone marrow suppression increases the risk of infections, anemia, and bleeding. Regular blood counts are vital to monitor this potential complication and guide treatment decisions, potentially requiring dose reductions or temporary treatment interruptions.

Liver toxicity is another significant concern, particularly in patients with pre-existing liver disease. Regular liver function tests are crucial to monitor for any signs of liver damage. In cases of significant liver impairment, treatment with Methotrexate-Ebewe may need to be adjusted or discontinued to prevent further liver injury.

The potential for long-term effects, such as lung damage and infertility, must also be considered. These risks underscore the importance of carefully weighing the benefits and risks of Methotrexate-Ebewe before initiating treatment. Open communication between the patient and the healthcare provider is vital to ensure informed decision-making and appropriate monitoring.

Precautions and Contraindications

Before initiating treatment with Methotrexate-Ebewe, several crucial precautions must be observed, and contraindications carefully considered. This medication is not suitable for all individuals, and its use requires careful assessment of potential risks versus benefits. Thorough patient evaluation is paramount.

Patients with pre-existing liver or kidney disease should be closely monitored during treatment, as Methotrexate-Ebewe can exacerbate these conditions. Regular blood tests are crucial to assess liver and kidney function and guide treatment decisions, potentially requiring dose adjustments or treatment discontinuation.

Individuals with compromised immune systems, such as those with HIV or undergoing immunosuppressive therapy, should exercise caution, as Methotrexate-Ebewe’s immunosuppressive effects may further weaken their defenses against infections. Close monitoring for infections is essential in this patient population.

Women of childbearing age should use effective contraception during treatment and for at least six months after discontinuation, as Methotrexate-Ebewe is a known teratogen, capable of causing severe birth defects. Pregnancy should be avoided during treatment and careful planning is crucial for women who wish to conceive after treatment.

Methotrexate-Ebewe is contraindicated in individuals with certain conditions, including significant bone marrow suppression, severe liver disease, or active peptic ulcers. Patients with known hypersensitivity to methotrexate should absolutely avoid this medication. Any history of significant allergic reactions should be thoroughly documented before treatment initiation.

Conclusion

Methotrexate-Ebewe injection solution represents a powerful and versatile therapeutic agent with significant applications in oncology and the management of autoimmune diseases. Its mechanism of action, targeting both rapidly dividing cells and immune system activity, makes it a valuable tool in various clinical settings. However, its potency necessitates careful consideration of potential risks.

The benefits of Methotrexate-Ebewe, including its efficacy in treating various cancers and autoimmune disorders, must be weighed against the potential for serious adverse effects, such as gastrointestinal toxicity, bone marrow suppression, and liver damage. The decision to use this medication should be made in consultation with a healthcare professional experienced in managing this potent drug.

Regular monitoring of blood counts and liver and kidney function is crucial throughout treatment. Strict adherence to the prescribed dosage and administration route is paramount. Patients should be fully informed about the potential benefits and risks associated with Methotrexate-Ebewe to ensure informed consent and participation in their treatment plan.

The information provided in this overview serves as a general guide and should not replace consultation with a qualified healthcare professional. Individual patient circumstances and medical history influence treatment decisions. Always consult a doctor or other qualified healthcare provider for any questions you may have regarding a medical condition or treatment and before undertaking a course of treatment.

Ultimately, the successful use of Methotrexate-Ebewe hinges on a collaborative approach between the patient and healthcare team, ensuring that the benefits of this powerful drug are maximized while potential risks are minimized through careful monitoring and management. Open communication and a shared understanding of the treatment plan are essential for optimal outcomes.

  • Methotrexate-Ebewe™ Injection Solution 10Mg/Ml (5Ml), Vial 1Pc Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Methotrexate-Ebewe™ Injection Solution 10Mg/Ml (5Ml), Vial 1Pc Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Methotrexate-Ebewe™ Injection Solution 10Mg/Ml (5Ml), Vial 1Pc Buy Online 6
    [Medical reviewer]

    Dr. Jessica Kerns is a highly accomplished pediatrician and adolescent medicine specialist who serves as a clinical instructor in the Department of Pediatrics at the Icahn School of Medicine at Mount...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “METHOTREXATE-EBEWE™ injection solution 10mg/ml (5ml), vial 1pc”

Your email address will not be published. Required fields are marked

Similar products

LESTRODEX™ tablets 2.5mg, 30pcs

$177.0
Add to cart

LETROZOLE tablets 2.5mg, 30pcs

$685.5
Add to cart

XTANDI™ capsules 40mg, 112pcs

$14,602.0
Add to cart

CLADRIBINE concentrate for infusion solution 1mg/ml (10ml), vial 1pc

$395.0
Add to cart

CARBOPLATIN-RONC™ concentrate for infusion solution 10mg/ml (45ml), vial 1pc

$209.0
Add to cart

CAPECITABINE tablets 500mg, 120pcs

$700.0
Add to cart

CABOMETYX™ tablets 20mg, 30pcs

$33,095.0
Add to cart

CABOMETYX™ tablets 60mg, 30pcs

$33,095.0
Add to cart

IRINOTECAN-TEVA™ concentrate for infusion solution 20mg/ml (2ml), vial 1pc

$132.0
Add to cart

IMFINZI™ concentrate for infusion solution 50mg/ml (10ml), vial 1pc

$13,556.5
Add to cart

ZENLISTIK™ tablets 200mg, 56pcs

$6,349.5
Add to cart

ZARSIO™ solution for IV and SC injection 48 million IU/0.5ml (0.5ml), syringes 5pcs

$1,680.5
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (16ml), vial 1pc

$1,185.5
Add to cart

HERCEPTIN™ lyophilisate for concentrate for infusion solution 440mg + solvent 20ml, vial 1pc

$2,567.5
Add to cart

HYDREA™ capsules 500mg, 20pcs

$21.5
Add to cart

HEMANGIOL™ oral solution 3.75mg/ml (120ml), vial 1pc

$1,509.0
Add to cart

VINBLASTIN-LENS™ lyophilisate for IV infusion 5mg, vial 1pc

$36.0
Add to cart

BLINCYTO™ powder for concentrate for infusion solution 35mcg+stabilizer, vial 1pc

$14,965.0
Add to cart

BICALUTAMIDE tablets 150mg, 30pcs

$199.5
Add to cart

BICALUTAMIDE tablets 50mg, 30pcs

$102.0
Add to cart

BARTIZAR™ lyophilisate for IV/SC injection 3.5mg, 1pc

$1,233.0
Add to cart

BAVENCIO™ concentrate for infusion solution 20mg/ml (10ml), vial 1pc

$4,871.0
Add to cart

ANASTROZOLE tablets 1mg, 30pcs

$106.0
Add to cart

ANAZALES™ tablets 1mg, 28pcs

$96.5
Add to cart
Select your currency